The Department of Neurosurgery and Neuro-oncology at Sun Yat-Sen University Cancer Center (SYSUCC) was founded in 2000, with the commitment to excellence in patient care, education and research. SYSUCC is one of the pioneering cancer centers in China, which provides specialized neurosurgical and neuro-oncological services for patients with central nervous system (CNS) tumors. Under the direction of the founder, Prof. Chen Zhong-ping, and the current chairman, Prof. Mou Yong-gao, our department has been ranked as one of the top medical units in the field of Neuro-oncology in China. The department is now composed 2 sections with a total of 72 ward beds. The team includes 13 neurosurgeons, 2 neuro-oncologists and 1 neuroelectrophysiologist, who care for more than 2,000 new patients with brain tumors and performed approximately 1,400 neurosurgical procedures each year.
Our department is committed to the diagnosis and treatment of malignant and benign CNS tumors, including glioma, meningioma, pituitary tumors, skull base tumors, pediatric brain tumors, and metastatic brain tumors. We take an integrated approach to provide the state-of-the-art and individualized treatment for brain tumor patients. As one of the best medical care units for managing patients with glioma in China, our department strives for standardized comprehensive treatment of not only gliomas but also other CNS tumors. The neurosurgeons are able to perform a full range of procedures applying modern microsurgical and image guided techniques to remove complex and deeply seated tumors, such as operable brain stem lesions, intramedullary tumors in the upper cervical segment, petroclival tumors, jugular foramen tumors, and tumors located at the thalamus. As one of the earliest nero-oncology units and also one of the medical centers for training neurooncologists in China, our department tailors chemotherapy strategies based on histopathology and the molecular profiles of the tumors. The CNS tumor multidisciplinary team (MDT) of SYSUCC comprises of neurosurgeons, radiation oncologists, medical oncologists, radiologists, pathologists and other specialists, who meet weekly to review tumor cases and create comprehensive treatment plans for patients.
Our surgeons and scientists perform unique, national funded research into methods for improving clinical outcomes; we initiated and participated in more than 10 clinical trials in the last 5 years. Thanks to the State Key Laboratory of Oncology in Southern China, the research team in our department has been working on the molecular mechanisms underlying the progression and treatment resistance of gliomas. In addition, core research interests is the development of novel treatment strategies such as targeted therapy and immunotherapy. In the last decade, more than 10 research projects have been supported by the National Natural Science Fund, and more than 300 manuscripts have been published.
Updated August 2020